BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21246178)

  • 1. [The various forms of left ventricular hypertrophy: diagnostic value of echocardiography].
    Weidemann F; Störk S; Herrmann S; Ertl G; Niemann M
    Herz; 2011 Dec; 36(8):713-23. PubMed ID: 21246178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The different faces of echocardiographic left ventricular hypertrophy: clues to the etiology.
    Weidemann F; Niemann M; Ertl G; Störk S
    J Am Soc Echocardiogr; 2010 Aug; 23(8):793-801. PubMed ID: 20591620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy.
    Liu D; Hu K; Niemann M; Herrmann S; Cikes M; Störk S; Gaudron PD; Knop S; Ertl G; Bijnens B; Weidemann F
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):1066-72. PubMed ID: 24100046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
    Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
    Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: are all etiologies identical?
    Ganame J; Pignatelli RH; Eidem BW; Claus P; D'hooge J; McMahon CJ; Buyse G; Towbin JA; Ayres NA; Mertens L
    Eur J Echocardiogr; 2008 Nov; 9(6):784-90. PubMed ID: 18490283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.
    Sun JP; Xu TY; Ni XD; Yang XS; Hu JL; Wang SC; Li Y; Bahler RC; Wang JG
    Echocardiography; 2019 Feb; 36(2):257-265. PubMed ID: 30561121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.
    Sun JP; Stewart WJ; Yang XS; Donnell RO; Leon AR; Felner JM; Thomas JD; Merlino JD
    Am J Cardiol; 2009 Feb; 103(3):411-5. PubMed ID: 19166699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.
    Maron BJ
    Eur Heart J; 1983 Nov; 4 Suppl F():73-91. PubMed ID: 6686547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular short-axis systolic function changes in patients with hypertrophic cardiomyopathy detected by two-dimensional speckle tracking imaging.
    Huang J; Yan ZN; Rui YF; Fan L; Liu C; Li J
    BMC Cardiovasc Disord; 2018 Jan; 18(1):13. PubMed ID: 29378516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovery of left ventricular hypertrophy during adult echocardiography].
    Dayal NB; Müller H
    Rev Med Suisse; 2017 May; 13(564):1106-1112. PubMed ID: 28639774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study.
    Keller H; Wanger KC; Goepfrich M; Stegaru B; Buss J; Heene DL
    Eur Heart J; 1990 Jan; 11(1):65-74. PubMed ID: 2137778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional echocardiography in myocardial amyloidosis.
    Picano E; Pinamonti B; Ferdeghini EM; Landini L; Slavich G; Orlandini A; Marini C; Lattanzi F; Camerini F
    Echocardiography; 1991 Mar; 8(2):253-9. PubMed ID: 10149255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of left ventricular hypertrophy seen on transthoracic echo in patients with hypertensive cardiomyopathy when compared with idiopathic hypertrophic cardiomyopathy.
    Mirza SJ; Radaideh GA
    J Pak Med Assoc; 2013 Jan; 63(1):16-9. PubMed ID: 23865125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of regional systolic function in hypertrophic cardiomyopathy and hypertensive heart disease: a three-dimensional echocardiographic study.
    Frielingsdorf J; Franke A; Kühl HP; Rijcken E; Krebs W; Hess OM; Flachskampf FA; Hanrath P
    J Am Soc Echocardiogr; 1998 Aug; 11(8):778-86. PubMed ID: 9719089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography.
    Iio C; Inoue K; Nishimura K; Fujii A; Nagai T; Suzuki J; Okura T; Higaki J; Ogimoto A
    Echocardiography; 2015 Dec; 32(12):1821-30. PubMed ID: 25959698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK; Senior R
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy.
    Kansal MM; Lester SJ; Surapaneni P; Sengupta PP; Appleton CP; Ommen SR; Ressler SW; Hurst RT
    Am J Cardiol; 2011 Nov; 108(9):1322-6. PubMed ID: 21855830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.